AmSurg receives ‘buy’ rating — 5 notes

Citigroup analysts gave AmSurg a “buy” rating, according to Baseball News Source.

Advertisement

Here are five notes:

1. On June 14, Wells Fargo gave AmSurg shares a “market perform” rating.

2. AmSurg’s 50-day moving average is $65.74.

3. The 200-day moving average is $73.68.

4. AmSurg has a 52-week low of $58.37 and a 52-week high of $87.29.

5. The company’s market cap. is $3.48 billion.

More articles on surgery centers:
Conifer Health to handle value-based care services for Canopy Health in CA: 3 things to know
Zacks gives SCA ‘sell’ rating — 5 notes
Dr. Craig Amshel opens surgery center to expand healthcare access to Floridians — 4 key points

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.